Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Published in: PharmacoEconomics 3/1998

01-03-1998 | Leading Article

The Role of Cost—Consequence Analysis in Healthcare Decision—Making

Authors: Dr Josephine A. Mauskopf, John E. Paul, David M. Grant, Andy Stergachis

Published in: PharmacoEconomics | Issue 3/1998

Login to get access
Metadata
Title
The Role of Cost—Consequence Analysis in Healthcare Decision—Making
Authors
Dr Josephine A. Mauskopf
John E. Paul
David M. Grant
Andy Stergachis
Publication date
01-03-1998
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 3/1998
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-199813030-00002

Other articles of this Issue 3/1998

PharmacoEconomics 3/1998 Go to the issue

Original Research Article

Economic Evaluation of Insulin Lispro versus Neutral (Regular) Insulin Therapy Using a Willingness—To—Pay Approach

Leading Article

Applications of Modelling Studies

Review Article

The Selection of Data Sources For Use in Modelling Studies

Original Research Article

Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial Infarction

Current Opinion

The Pros and Cons of a Single ‘Euro—Price’ For Drugs

Adis Pharmacoeconomic Drug Evaluation

Meropenem